Avramiotis S. Nikolaos, MD, MSc
@NSAvramiotis
Followers
70
Following
307
Media
1
Statuses
70
Neurology Resident @UniSpitalBasel with an orientation in Stroke Medicine
Basel, Switzerland
Joined February 2022
RT @ESOstroke: 🚨 Keynote Alert at #ESOC2025!.GOLDEN BRIDGE II shows AI-driven clinical decision support can improve stroke recurrence rates….
0
4
0
RT @ESOstroke: ESTREL trial at #ESOC2025: Levodopa did not boost motor recovery after stroke, but extensive ESTREL data may pave the way fo….
0
8
0
Blazing-fast image creation – using just your voice. Try Grok Imagine.
283
567
3K
RT @WorldStrokeEd: #ESOC2025.🧠Covert Brain Infarction.⬆️Increase risk of Stroke ~2x.📈More CBI, more risk. ☝️Inform the patient .🚭Treat ris….
0
8
0
RT @ESOstroke: Presented at #ESOC2025: Tirofiban, an IV antiplatelet, given as an adjunct to IVT, improved the odds of excellent functional….
0
19
0
RT @ESOstroke: New DISTAL Trial sub-analysis: Endovascular therapy boosted chances of saving at least 80% of affected brain tissue in mediu….
0
18
0
RT @WorldStrokeEd: #ESOC2025.🏃🏻♀️ESCAPE MEVO sub analysis . 👉🏻 prognosis by image 🧠.👉🏻EVT <12 hs not > good functional outcome .👉🏻 Good co….
0
31
0
RT @ESOstroke: #ESOC2025 | The OPTIMIST trial suggests low-intensity monitoring after IV thrombolysis in mild to moderate stroke can delive….
0
13
0
RT @ESOstroke: BRIDGE TNK trial presented at #ESOC2025 shows superior outcomes with IV Tenecteplase + thrombectomy vs thrombectomy alone in….
0
15
0
RT @WorldStrokeEd: #ESOC2025.✅ASSET-IT: early tirofiban after IVT. 👉🏻>mRS 0-1 and 0-2 at 90 day in Tirofiban arm. 👉🏻 = sICH and mortality a….
0
22
0
RT @WorldStrokeEd: 🚨Neuroprotective agents in Large Core Strokes. 👉🏻 Edaravone + Dexborneol vs usual care.👉🏻 < 14 days of onset. ✅ drugs: b….
0
18
0
RT @ESOstroke: 🚨EXCOA-CVT trial at #ESOC2025:Extending oral anticoagulation after cerebral vein thrombosis shows no clear benefit vs. short….
0
27
0
RT @NN_publishing: The "first" subanalysis from the @DistalTrial is disclosed by Aikaterini Anastasiou, with results across 447 patients su….
0
20
0
RT @DrYukselUrun: BREAKING from @NEJM .In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) i….
0
391
0
RT @ShadiYaghi2: A STOP-CAD secondary analysis engineered by @DrDanielMandel : Among high risk features identified in cervical artery disse….
ahajournals.org
BACKGROUND: Patients presenting with cervical artery dissection (CAD) are at risk for subsequent ischemic events. We aimed to identify characteristics that are associated with increased risk of...
0
35
0
Amazing international multi-cohort collaboration just published @JAMANeuro . Thanks @mbgoeldlin @DavidSeiffge for the amazing work and opportunity to be part of this great work!.
Recurrent intracerebral hemorrhage (ICH) adjacent to a previous ICH is a phenomenon associated with early recurrence and features of cerebral amyloid angiopathy.
0
1
4
RT @JAMANeuro: Author David Seiffge discusses "Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage" with JAMA Neurology….
edhub.ama-assn.org
Interview with David J. Seiffge, MD, author of Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. Hosted by Cynthia E. Armand, MD.
0
11
0
RT @DavidSeiffge: EURECA: New data on recurrent ICH: every second recurrence is adjacent to index ICH. Those bleedings occur early and are….
edhub.ama-assn.org
Interview with David J. Seiffge, MD, author of Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage. Hosted by Cynthia E. Armand, MD.
0
30
0
RT @Marinos_S: New publication: CHANTER is an under-recognized syndrome of multifocal cerebral edema after opioid ingestion. It's important….
0
56
0
RT @adnan_mujanovic: @almuftifawaz @Starkeneurosurg @Ansaar_Rai @NguyenThanhMD @CerebrovascLab @elghanemmoh @_AdnanSiddiqui @AmeerEHassan @….
ajnr.org
BACKGROUND AND PURPOSE: Potential utility of flat panel CT perfusion imaging (FPCT-PI) performed immediately after mechanical thrombectomy (MT) is unknown. We aimed to assess whether FPCT-PI obtained...
0
10
0